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IMPORTANCE Survivors of sepsis face long-term sequelae that diminish health-related quality
of life and result in increased care needs in the primary care setting, such as medication,
physiotherapy, or mental health care.
OBJECTIVE To examine if a primary care–based intervention improves mental health–related
quality of life.
DESIGN, SETTING, AND PARTICIPANTS Randomized clinical trial conducted between February
2011 and December 2014, enrolling 291 patients 18 years or older who survived sepsis
(including septic shock), recruited from 9 intensive care units (ICUs) across Germany.
INTERVENTIONS Participants were randomized to usual care (n = 143) or to a 12-month
intervention (n = 148). Usual care was provided by their primary care physician (PCP) and
included periodic contacts, referrals to specialists, and prescription of medication, other
treatment, or both. The intervention additionally included PCP and patient training, case
management provided by trained nurses, and clinical decision support for PCPs by
consulting physicians.
MAIN OUTCOMES ANDMEASURES The primary outcomewas change inmental health–related
quality of life between ICU discharge and 6months after ICU discharge using theMental
Component Summary (MCS) of the 36-Item Short-FormHealth Survey (SF-36 [range, 0-100;
higher ratings indicate lower impairment; minimal clinically important difference,
5 score points]).
RESULTS Themean age of the 291 patients was 61.6 years (SD, 14.4); 66.2% (n = 192)were
men, and 84.4% (n = 244) requiredmechanical ventilation during their ICU stay (median
duration of ventilation, 12 days [range, 0-134]). At 6 and 12months after ICU discharge, 75.3%
(n = 219 [112 intervention, 107 control]) and 69.4% (n = 202 [107 intervention, 95 control]),
respectively, completed follow-up. Overall mortality was 13.7% at 6months (40 deaths [21
intervention, 19 control]) and 18.2% at 12months (53 deaths [27 intervention, 26 control]).
Among patients in the intervention group, 104 (70.3%) received the intervention at high levels
of integrity. Therewas no significant difference in change ofmeanMCS scores (intervention
groupmean at baseline, 49.1; at 6months, 52.9; change, 3.79 score points [95%CI, 1.05 to
6.54] vs control groupmean at baseline, 49.3; at 6months, 51.0; change, 1.64 score points
[95%CI, −1.22 to 4.51]; mean treatment effect, 2.15 [95%CI, −1.79 to 6.09]; P = .28).
CONCLUSIONS AND RELEVANCE Among survivors of sepsis and septic shock, the use of a
primary care–focused team-based intervention, compared with usual care, did not improve
mental health–related quality of life 6months after ICU discharge. Further research is needed
to determine if modified approaches to primary care management may bemore effective.
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S epsis is amajor health problemworldwide.1 It has beenestimated that sepsis occurred in 2%ofhospitalizedpa-tients in the United States in 2008, and incidence is ex-
pected to increase further in the future, with an even higher
incidence indevelopingcountries.2The riskofdying fromsep-
sis has decreased in recent decades, owing to earlier detec-
tion and more effective treatment.3 Although more patients
survive sepsis and are increasingly discharged from the
hospital,4 they often experience functional disability, cogni-
tive impairment, and psychiatricmorbidity,5,6 resulting in di-
minishedhealth-relatedquality of life,7 increasedhealth care
costs,8,9 and burden on patients and their families.7,10
Many survivors of sepsis have multiple medical comor-
bidities that are typicallymanaged in primary care. Yet inter-
ventions for managing sepsis sequelae in primary care have
not been developed.5,11 A systematic review of outpatient in-
terventions for patients surviving critical illnesses showed
heterogeneous and small effects on clinical outcomes such as
depression and symptoms of posttraumatic stress disorder
(PTSD).12 Studies with post–intensive care unit (ICU) follow-
ups of 6 months or more are rare.7
The purpose of this randomized clinical trial was to as-
sess whether a primary care–based intervention13 would im-
provemental health–relatedquality of life among survivors of
sepsis compared with usual care.
Methods
Study Design and Population
A multicenter, unblinded, 2-group randomized clinical
trial was performed. The institutional review board of the
Jena University Hospital approved the study protocol (proto-
col available in Supplement 1). All patients and primary care
physicians (PCPs) in the study provided written informed
consent. Serious adverse events were reported to a data
and safety monitoring board. Patients were recruited in 9 ICU
study centers across Germany between February 2011 and
December 2013. Follow-up assessments were completed
in December 2014. Patients were eligible for inclusion if
they were adult (≥18 years) survivors of severe sepsis, (now
defined as “sepsis”14) or septic shock and fluent in the
German language.
Clinical diagnoses of sepsis were made by intensivists
according to International Statistical Classification of Diseases
and Related Health Problems, Tenth Revision codes (R65.1/
R57.2) and American College of Chest Physicians/Society of
Critical Care Medicine consensus criteria.15 Baseline inter-
views of patients were conducted by the study team within 1
month of ICU discharge. The key exclusion criterion was cog-
nitive impairment, as determined by the Telephone Inter-
view of Cognitive Status (score ≤27).16 After determining
patient eligibility, the study team invited each patient’s PCP
to participate in the trial.
Randomizationwasstratifiedby ICUstudycentersandper-
formedusingcomputer-generated randompermutatedblocks
(block size range, 2-6) provided by an independent center for
clinical trials at the University of Leipzig.
Intervention
The intervention was based on the chronic care model.17 Its
core components includedcasemanagement focusingonpro-
active patient symptom monitoring, clinical decision sup-
port for the PCP, and training for both patients and their PCPs
inevidence-basedcare.Threenurseswith ICUexperiencewere
trained as outpatient casemanagers for survivors of sepsis in
an8-hourworkshop.Thetraining included informationonsep-
sis sequelae, communicationskills, telephonemonitoring, and
behavioral activation of patients that included goal setting
(SepsisCaseManagerManual inSupplement2).Eachcaseman-
agerworkedwith 38 to 65 patients, startingwith a 60-minute
face-to-face training on sepsis sequelae (Sepsis Help Book in
Supplement2) that tookplace amedianof8days after ICUdis-
charge (interquartile range [IQR], 2-20). Thiswas followed by
monthly telephone contact for 6 months, then once every 3
months for the final 6months. Casemanagersmonitored pa-
tients’ symptomsusingvalidatedscreening tools (SepsisMoni-
toringChecklist inSupplement2) to assess critical illnesspoly-
neuropathy/myopathy,wasting,neurocognitivedeficits,PTSD,
depressive and pain symptoms, as well as patient self-
management behaviors focusing on physical activity and in-
dividual self-management goals. Each case manager re-
ported results to 1of 3 assignedconsultingphysicians (medical
doctorswithbackground inprimaryandcritical care),whosu-
pervised thecasemanagersandprovidedclinicaldecisionsup-
port to the PCPs using a structured written report that in-
cluded theSepsisMonitoringChecklist (Supplement2; eFigure
3 inSupplement3).Thereportswerestratifiedbyurgencyusing
a traffic-light scheme: red signified “immediate intervention
recommended”; yellow, “intervention should be consid-
ered”; and green, “acceptable clinical status.” Evidence-
based sepsis aftercare training for the patients’ PCPswas pro-
vided in person on an individual basis by the consulting
physicians (Sepsis PCP Manual in Supplement 2). Interven-
tiondeliverywas considered tohavehigh integrity if the train-
ing was delivered both to patients and to PCPs and the pa-
tient was monitored 5 or more times.
Patients in the control group received care as usual from
their PCPs without additional information or monitoring.
Usual sepsis aftercare included periodic contacts, referrals to
specialists, and prescription of medication and therapeutic
aids at quantities comparable with those for other popula-
tions with multiple chronic conditions.18 In Germany, most
primary care practices are privately operated by 1 or 2 PCPs,
with limited access to specialist care.19 There are no outpa-
tient postsepsis/ICU follow-up clinics or national treatment
guidelines for sepsis aftercare in Germany.
Baseline Data andOutcomes
Baseline datawere collected at in-person interviewswith pa-
tients while they were still hospitalized. Further clinical data
wereobtained fromtheir ICU records. Since themajorityofpa-
tients remainedhospitalized and incapacitated, baselinedata
collection of activities of daily living (ADL), physical func-
tion, and insomnia was not feasible.
The primary outcome was change in mental health–
relatedqualityof lifebetweenICUdischargeand6monthsafter
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ICU discharge, as assessed by the Mental Component Sum-
mary (MCS) score of the 36-Item Short Form Health Survey
(SF-36 [range, 0-100; higher scores indicate lower levels of
impairment20]). The SF-36 consists of 8 subscores and is valid
and reliable in both post-ICU discharge21 and German pri-
mary care populations.22
Secondary outcomes at 6 months were derived from
(1) the other SF-36 scales (range, 0-100; higher scores
indicate lower levels of impairment); (2) overall survival;
(3) mental health outcomes, including the Major Depression
Inventory (range, 0-50; higher scores indicate greater
impairment23), the Posttraumatic Symptom Scale (range, 10-
70;higher scores indicategreater impairment24), and theTele-
phone InterviewofCognitiveStatus (range,0-50;higher scores
indicate greater impairment16); (4) functional outcomes in-
cluding ADL (range, 0-11; higher scores indicate lower levels
of impairment25), the Extra Short Musculoskeletal Function
Assessment regarding physical function (XSFMA-F) and dis-
ability (XSMFA-B [range for both, 0-100; higher scores indi-
cate greater impairment26), theGradedChronic Pain Scale in-
cluding a Disability Score and Pain Intensity (range, 0-100;
higher scores indicate greater impairment27), the Neuropa-
thySymptomScore (range,0-10;higher scores indicategreater
impairment28), the Malnutrition Universal Screening Tool
(range, 0-2; higher scores indicate greater impairment29) in-
cludingbodymass index,30andtheRegensburg InsomniaScale
(range 0-40; higher scores indicate greater impairment31).
Process-related outcomes included the Patient Assess-
mentofCare forChronicConditions (range,0-10;higher scores
indicate lower levelsof impairment)32,33 andmeasuresofmedi-
cation adherence, the modified Morisky questionnaire (range
1-5; higher scores indicate greater impairment,34 and the Short
Form for Medication Use (range, 0-12; higher scores indicate
greater impairment.35 Inaddition,process-relateddatafromPCP
documentationwerederived, includingPCPcontacts (No.), re-
ferrals to specialists (No.), level of nursing, inability to work
(days), remedies and therapeutic aids (No.), and length of
stay in the hospital and rehabilitation clinic (days). All 31 sec-
ondary outcomes prespecified in the statistical analysis plan
(Supplement 4) are reported in eTables 2-8 in Supplement 3.
In addition, we also included as secondary outcomes all
of the above measured at 12 months after ICU discharge.
Outcome assessment was conducted by nonblinded asses-
sors by telephone.
Initially, theMCSaswell as thePhysical Component Sum-
mary score of the SF-36 were chosen for primary outcome to
provideamulticomponentscore reflectinghealth-relatedqual-
ity of life (as noted in the study protocol13 and the ISRCTN
registration).However,basedonreviewof the literature12high-
lighting the importance of mental health outcomes in post-
ICU care, the primary outcome was specified to the MCS.
Statistical Analysis
The aim of the studywas to detect a difference at 6months of
5pointsormoreinmeanMCSscores,sincethisamountofchange
is thought to be clinically meaningful.22 A common standard
deviation of 10 was assumed on the basis of a typical German
populationwith acute and chronic diseases.36 At a 2-sided sig-
nificance level of α = .05, a total of 2 × 86 = 172 patients were
required to detect the above-mentioned effectwith a power of
90%. Allowing for an additional approximately 40% for drop-
outs andmortality, an initial sample size of 287 was required.
The confirmatory test for the primary outcome was the
Welch t test for independent groups, whichwas run in the in-
tention-to-treatpopulation.Theconfirmatoryanalysesdidnot
consider intrapractice clusteringbecause 155 (96.9%)of inter-
vention practices and 141 (95.1%) of control practices in-
cluded only 1 patient. The effect clustering and missing val-
ueswereexploredusing, forexample, linearmixedmodelsand
imputationsby regressionmodels.Details onmethods and re-
sults of exploratory sensitivity analyses are provided in the
eMethods in Supplement 3.
All secondary outcome analyseswere exploratory andnot
adjustedformultipletests.Theseanalyseswereperformedusing
the t test, Fisher exact test, and the Wilcoxon-Mann-Whitney
test, as appropriate. Overall survival was estimated using the
Kaplan-Meiermethod, with study groups compared using the
log-rank test. A confirmatory and exploratory 2-sided signifi-
cance levelofα = .05wasapplied,andeffect sizeestimateswith
95% confidence intervals were reported.
All statisticalanalyseswereperformedusingRversion3.2.3
(R Project for Statistical Computing).37
Results
Baseline Characteristics
Atotalof361patientswereeligible,ofwhich291 (80.6%)agreed
toparticipate,with148patients randomizedto the intervention
and143patients to thecontrol group (Figure).Overall, baseline
characteristicswerewell balanced (Table). Themeanageof the
cohortwas 61.6 years (SD, 14.4); 244patients (84.4%) received
mechanical ventilation, and themedian ICU lengthof staywas
26 days (IQR, 13-46). Mental health–related quality of life was
closetothatofthenormalpopulation(meanMCSscore,49.0[SD,
12.5]), physical health–relatedqualityof lifewas low (meanSF-
36 [PhysicalComponent Summary] score, 25.3 [SD,8.8]); 68of
281 (24.2%) had substantial depressive symptoms, 41 of 281
(14.6%) reported substantial PTSD symptoms, and 54 of 276
(19.6%) indicatedseverepain (Table).Among theentire cohort,
164 of 277 (59.2%) reported neuropathic symptoms.
Follow-up
All included 291 patients were cared for by 159 intervention
PCPs and 148 control PCPs. Because of somepatient-initiated
PCP changes, the number of PCPswas slightly larger than the
number of patients (eMethods in Supplement 3). Among the
307assignedPCPs,294(95.8%)werewillingtoparticipate.Loss
to follow-updue towithdrawal or nonresponse totaled66pa-
tients (22.7%) at6months andanadditional 18patients (6.2%)
at 12 months after ICU discharge and was evenly distributed
across study groups (Figure).
Intervention Delivery
Of the 148 patients assigned to the intervention, 130 (87.8%)
received patient training from case managers; 125 (84.5%) of
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theirPCPs received training fromaconsultingphysician.There
was a mean gap of 62.38 days (IQR, 36-99) between ICU dis-
charge and PCP training, caused by the wide range of patient
clinical courses. One hundred-four patients (70.3%) in the in-
terventiongroupreceived theplanned interventionathigh lev-
els of intervention integrity (eFigure 2 in Supplement 3). In-
complete interventionwasusually attributable todeathof the
patient (24 [54%]of thosewith fewer than5monitoring calls).
Reduction ofmotor function (204 [27.1%]) and pain intensity
(201 [27.2%])were thepostsepsis symptomsmost rated “red”
(ie, “immediate intervention recommended”) in all 756 struc-
tured monitoring reports (eTable 10 in Supplement 3).
No adverse events related to the intervention were
reported.
Primary Outcome
There was no significant difference between groups in the
primary outcome: The mean change MCS score was 3.79
score points (95% CI, 1.05 to 6.54) for the intervention group
and 1.64 score points (95% CI, 1.22 to 4.51) for the control
group, leading to a mean treatment effect of 2.15 (95% CI,
−1.79 to 6.09); P = .28; baseline mean, 49.1 for intervention
vs 49.3 for control; 6-month mean, 52.9 for intervention vs
51.0 for control (all data related to n = 200 patients [n = 104
intervention, n = 96 control]), with bothMCS scores available
at baseline and 6 months; due to rounding, change scores
presented may not add up precisely). These results were
unchanged in several sensitivity analyses (eTable 1 in
Supplement 3).
Figure. CONSORT FlowDiagram of Patient Recruitment and Retention During the Study
321 Excluded
160 Met exclusion criteria
12 Did not meet sepsis criteria
80 Reasons not specified
123 Died
38 Could not be reached
54 Cognitive deficit
14 Speech impairment
70 Excluded (declined to participate)
148 Randomized to receive primary
care based intervention
148 Completed baseline case report
form and received intervention
as randomized
143 Randomized to receive usual care
142 Completed baseline case report
form and received usual care as
randomized
1 Died
32 Withdrew from study
21 Died
11 Discontinued follow-up
3 Refused for health reasons
5 Refused for unspecified reasons
3 Could not be reached
34 Withdrew from study
19 Died
15 Discontinued follow-up
3 Refused for health reasons
9 Refused for unspecified reasons
3 Could not be reached
8 Withdrew from study between
6 and 12 mo
6 Died
1 Refused for health reasons
1 Could not be reached
10 Withdrew from study between
6 and 12 mo
7 Died
2 Could not be reached
1 Refused for other reasons
104 Included in primary analysis
8 Excluded (missing baseline
or 6-mo data)
96 Included in primary analysis
11 Excluded (missing baseline
or 6-mo data)
112 Completed 6-mo follow-up
4 Missed 6-mo follow-up
(remained in study)
107 Completed 6-mo follow-up
1 Missed 6-mo follow-up
(remained in study)
107 Completed 12-mo follow-up
1 Missed 12-mo follow-up
95 Completed 12-mo follow-up
3 Missed 12-mo follow-up
361 Met inclusion criteria
291 Randomized
682 Patients approached by ICU
intensivists
ICU indicates intensive care unit.
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Table. Baseline Characteristics
Characteristic
All
(N = 290)
Intervention
(n = 148)
Control
(n = 142)
Not Available
Intervention Control
Sociodemographics
Age, mean (SD), y 61.6 (14.4) 62.1 (14.1) 61.2 (14.9) 0 0
Men, No. (%) 192 (66.2) 105 (70.9) 87 (61.3) 0 0
Married, No. (%) 148 (52.1) 84 (57.9) 64 (46.0) 3 3
Educational status <high school,
No. (%)
98 (34.0) 54 (36.7) 44 (31.1) 1 1
Care Measures
Recent surgical history, No. (%) 2 1
Emergency 106 (36.8) 49 (33.6) 57 (40.1)
Elective 62 (21.5) 34 (23.3) 28 (19.7)
No history 73 (25.3) 39 (26.7) 34 (23.9)
Source of infection, No. (%) 5
Community acquired 102 (36.0) 54 (37.2) 48 (34.8)
Nosocomial
ICU or intermediate care 139 (49.1) 70 (48.3) 69 (50.0)
General ward or nursing home 42 (14.8) 21 (14.5) 21 (15.2)
ICU length of stay, d 16 11
Mean (SD) 34.4 (27.2) 31.5 (27.7) 35.2 (26.7)
Median (IQR) 26 (4-27) 23 (4-26) 29 (5-28)
Mechanical ventilation, No. (%) 244 (84.4) 121 (82.3) 123 (86.6) 1 1
If applicable, d 5 4
Mean (SD) 18.5 (19.2) 17.0 (17.5) 19.9 (20.7)
Median (IQR) 12 (4-27) 10 (4-26) 14 (5-28)
Renal replacement therapy, No. (%) 82 (28.5) 43 (29.3) 39 (27.7) 1 2
If applicable, d 5 5
Mean (SD) 12.3 (13.2) 11.9 (13.7) 12.8 (12.8)
Median (IQR) 8 (4-15) 7 (4-14) 8 (5-16)
Clinical Measures
Charlson Comorbidity Index,
mean (SD)a
4.0 (2.9) 4.0 (3.0) 4.0 (2.9) 1 1
ICD-10 diagnoses, No. 6 7
Median 9 9 10
Mean (SD) 10.1 (4.7) 9.6 (4.4) 10.6 (5.1)
BMI, mean (SD) 27.3 (6.0) 27.3 (6.0) 27.3 (5.9) 3 9
Depression 3 6
MDI, mean (SD)b 18.1 (10.0) 18.4 (9.8) 17.8 (10.1)
Depressive symptoms, No. (%) 68 (24.2) 36 (24.8) 32 (23.5)
PTSD 3 6
PTSS-10, mean (SD)c 23.6 (10.4) 24.0 (11.0) 23.2 (9.7)
Score >35, No. (%) 41 (14.6) 22 (15.2) 19 (14.0)
TICS-M, mean (SD)d 33.4 (3.6) 33.7 (3.4) 33.1 (3.9) 1 0
Neuropathic symptoms 4 9
NSS, mean (SD)e 3.6 (3.2) 3.6 (3.3) 3.7 (3.1)
Score 3-10, No. (%) 164 (59.2) 83 (57.6) 81 (60.9)
Pain
Intensity: GCPS PI, mean (SD)f 43.8 (24.4) 43.7 (25.6) 43.9 (23.1) 5 9
Disability: GCPS DS, mean (SD)f 36.2 (34.6) 36.0 (34.5) 36.4 (34.8) 7 12
Severe pain: GCPS category >1,
No. (%)
54 (19.6) 26 (18.2) 28 (21.0) 5 9
Health-Related Quality of Life, Mean (SD)g
SF-36 12 15
MCS 49.0 (12.5) 48.8 (12.5) 49.2 (12.6)
PCS 25.3 (8.8) 25.9 (9.4) 24.7 (8.0)
Abbreviations: BMI, bodymass index;
GCPS DS, Graded Chronic Pain Scale
Disability Score; GCPS PI, Graded
Chronic Pain Scale Pain Intensity;
ICD-10, International Statistical
Classification of Diseases and Related
Health Problems, Tenth Revision;
ICU, intensive care unit; MDI, Major
Depression Inventory;
NSS, Neuropathic Symptom
Score; PTSD, Posttraumatic Stress
Disorder; PTSS, Posttraumatic
Symptom Scale; SF-36MCS, Short
Form 36 Health SurveyMental
Component Score; SF-36 PCS, Short
Form 36 Health Survey Physical
Component Score; TICS-M, modified
Telephone Interview
for Cognitive Status.
a Range of possible scores, 0-37. High
score indicates high impairment.
bRange of possible scores, 0-50.
High score indicates high
impairment.
c Range of possible scores, 10-70.
High score indicates high
impairment.
dRange of possible scores, 0-50;
includes only values greater than 27
(inclusion criterion). High score
indicates low impairment.
e Range of possible scores, 0-10. High
score indicates high impairment.
f The range of possible scores is
0-100. High score indicates high
impairment.
g Range of possible scores, 0-100.
High score indicates low
impairment.
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Secondary Outcomes
A total of 63 secondary outcomeswere analyzed at both6 and
12 months (including the 12-month MCS score).
A respective 28 (6 months) and 30 (12 months) outcomes
didnot showsignificantdifferences (at anuncorrectedα = .05)
between both groups, including physical health–related qual-
ity of life and mental health outcomes (eTable 2 and eTable 3
in Supplement 3). Overall mortality was 13.7% (n = 40) at 6
months after ICUdischarge and 18.2% (n = 53) at 12months af-
ter ICU discharge (eFigure 1 in Supplement 3). If any, potential
intervention effects were observed in measures of functional
outcomes only: at 6months, sepsis survivors receiving the in-
tervention had better physical functioning (mean XSFMA-F
score, 38.0 [95%CI, 32.5 to43.5] vs46.9 [95%CI, 40.9 to52.9];
P = .04; difference, −8.9 [95%CI, −17.02 to −0.78]), less physi-
caldisability (meanXSFMA-Bscore,42.5 [95%CI, 36.6 to48.4]
vs52.4 [95%CI,46.2 to58.7];P = .03;difference,−9.9 [95%CI,
−18.49 to −1.31]), and fewerADL impairments (mean, 8.6 [95%
CI, 8.0 to 9.1] vs 7.6 [95%CI, 7.0 to 8.2];P = .03; difference, 1.0
[95% CI, 0.16 to 1.84]) than usual care. After adjusting for pre-
specified baseline covariates, these potential effectswere per-
sistent. In addition, survivors of sepsis receiving the interven-
tionhadpotentially fewer sleep impairmentsat 12monthsafter
ICUdischarge thancontrols (meanRegensburg InsomniaScale
score, 10.3 [95%CI,9.2 to 11.4]vs 12.1 [95%CI, 10.8 to 13.4]; dif-
ference, −1.8 [95% CI, −3.5 to −0.10]).
In addition, the PCP documentation data at 6 and 12
monthsprovidednoevidence forgroupdifferences inPCPcare
(eTable 8 in Supplement 3).
Discussion
Among survivors of sepsis, a primary care–based interven-
tion,comparedwithusualcare,didnot improvementalhealth–
related quality of life.
To our knowledge, this is the first large-scale, random-
ized controlled clinical trial of an intervention to improveout-
comes in survivors of sepsis in primary care.
This sample of survivors of sepsis had similar mean
agesandratesofexistingcomorbiditiesascomparedwithother
cohorts.38,39 The prevalence of depressive and PTSD symp-
toms was slightly less than that among other populations of
survivors of critical illness,40,41 whereas neuropathic symp-
toms and severe painweremore frequent.42,43 Physical func-
tion,asmeasuredbytheSF-36PhysicalFunctionsubscore,was
substantially lower than in theGermanpopulation (mean,85.71
[SD, 22.1]; n = 2886)36 and also lower than in some compa-
rable cohorts44,45 and intervention studies.46,47 Thus, pa-
tients may have beenmore sensitive to the intervention’s fo-
cus on increasing motivation to be physically active.
Study patients were exposed to longer durations of me-
chanical ventilation and ICU length of stay than reported in
other studies.4 ICU length of stay and duration ofmechanical
ventilationwere shown to generally be longer in Europe than
in the United States, especially in survivors of sepsis.48,49 In
addition, extensive ICU lengthof staymayhave facilitatedpa-
tient identification by the intensivists.
There was no evidence for a differential treatment effect
on the study’s primary outcome, postsepsis MCS scores. This
finding is similar to those from previous trials of care man-
agement interventions following critical illness.12,46,47,50 The
absence of an intervention effect on the primary and most
secondary outcomes can be considered using the PICO
(Population, Intervention, Controls, Outcome) frameworks.51
Population
The studied cohort experienced heterogeneous clinical mul-
tiple conditions. This primary care–based intervention may
not have been sufficiently focused to address all their diverse
medical and psychological needs.52 Future trials may evalu-
ate interventions in different patient subgroups targeting
specific postsepsis sequelae. Larger samples should be
included to address smaller but potentially still clinically rel-
evant effects of primary care interventions.
Intervention
The exploratory analyses indicated no intervention effects on
mental health symptoms. These results may reflect lack of
intervention intensity and specificity or absence of clinically
effective interventions. However, there is growing evidence
that after critical illness, mental health outcomes can be
improved through effective psychological interventions tar-
geting specific syndromes.52,53
Controls
According to process data derived from control PCPs (eTable
8 in the Supplement), usual sepsis aftercare in Germany
seems to be highly intensive. PCP training and consultation
may have been insufficient to yield a meaningful improve-
ment in the level of care. Observational researchmay provide
more insights into existing usual sepsis aftercare in diverse
health care systems.
Outcome
The wide range of postsepsis sequelae may not be adequately
reflected in a rather global outcome measure, such as
change in SF-36 MCS score. Furthermore, the cohort’s base-
line mental health–related quality of life was similar
to healthy population norms in Germany, reflecting a limited
potential for improvement in the MCS score. Last, the exclu-
sion of patients with more severe cognitive dysfunction
may have led to a ceiling effect compared with other trials.
For future trials, more specific primary outcomes should
be considered.
Up to years after the ICU discharge, many patients seem
to share their needs with a reliable medical professional.54
Yet the PCP is not involved systematically in post-ICU
care.55,56 This study may shed light on PCP relevance,
addressing major concerns recently identified as “barriers to
practice.”57 These include checks on transition from ICU
through to community reintegration, linkage, and clinical
decision support to primary care, inclusion of a case
manager, and educational information for patients and
PCPs. Compared with the large-scale PRACTICAL trial on
follow-up care in ICU clinics,47 this study defines a clear
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function for the PCP in sepsis aftercare. Follow-up care com-
bining specialized ICU clinics and integrated PCPs may
improve outcomes.
This study’s exploratory findings suggest possible im-
provements of physical function and ADL impairments. Ad-
ditional research is needed to confirm these results. Possible
mechanisms of action for these findings may include in-
creased patient motivation (despite the presence of pain) to
partake inphysical activityowing to regular casemanager tele-
phone callswith goal-setting and basic behavioral activation.
Increased PCP supportiveness in the intervention groupmay
alsohavemotivatedpatients tobemoreproactive, possibly re-
flected by the increased rating in number of Patient Assess-
ment of Care for Chronic Conditions items (eTable 9 in
Supplement 3).
This study has strengths and limitations. It was possible
to enroll a large number of patients in spite of the challenges
of recruiting critically ill patients for research.58 Intervention
integrity went as planned59 (eFigure 2 in Supplement 3), in-
cluding the acceptance of an external medical consultant by
the patient’s PCP. These findings are encouraging for further
interventions in the primary care setting.
Loss to follow-up was balanced between the groups and
low, in contrast to sample size calculations that allowed for
40% dropout. Baseline values were missing for some second-
ary outcomes owing to patients’ severely impaired clinical
condition. A carryover effect (from treatment to control) may
have occurred for 1 PCP, inducing a bias toward a null effect.
Calling control patients to collect follow-up data may have
led to an intervention effect, possibly leading to underesti-
mation of the intervention effects.60 In addition, nonblinded
outcome assessments also may have biased the results.61 The
intervention is not generalizable to all survivors of sepsis in
various outpatient settings.
Conclusions
Among survivors of sepsis or septic shock, the use of a pri-
mary care–focused team-based intervention, compared with
usual care, did not improve mental health–related quality of
life 6months after ICU discharge. Further research is needed
todetermine ifmodified approaches toprimary caremanage-
ment may be more effective.
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